Infectious complications in patients with psoriasis and rheumatoid arthritis treated with antitumor necrosis factor agents and methotrexate

Authors :: Darabi, Kamruz
Jaiswal, Rohit
Hostetler, Sarah
Bechtel, Mark
Zirwas, Matthew
Source :: Journal of Drugs in Dermatology. Feb, 2009, Vol. 8 Issue 2, p175, 4 p.
Publication Year :: 2009
Abstract: ABSTRACT Treatment of patients with moderate-severe psoriasis and/or psoriatic arthritis includes systemic biologic, antimetabolite, and immunosuppressive therapy. However, adverse events such as serious infectious complications must be considered before starting [...]

Subjects :: Psoriasis -- Complications and side effects
Psoriasis -- Drug therapy
Psoriasis -- Patient outcomes
Psoriasis -- Case studies
Etanercept -- Dosage and administration
Etanercept -- Case studies
Etanercept -- Patient outcomes
Etanercept -- Complications and side effects
Methotrexate -- Case studies
Methotrexate -- Dosage and administration
Methotrexate -- Patient outcomes
Methotrexate -- Complications and side effects
Rheumatoid arthritis -- Case studies
Rheumatoid arthritis -- Patient outcomes
Rheumatoid arthritis -- Drug therapy
Rheumatoid arthritis -- Complications and side effects
Health
Pharmaceuticals and cosmetics industries

Tools